Showing 1 - 16 results of 16 for search 'Krittiya Korphaisarn', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
-
5
Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Pros... by Jirawat Thanestada MD, Varalak Srinonprasert MD, Akarin Nimmannit MD, Krittiya Korphaisarn MD, Pornpoj Pramyothin MD, Charuwan Akewanlop
Published 2022-06-01
Article -
6
Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study by Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun
Published 2021-04-01
Article -
7
Obesity Significantly Affects the Incidence of Hepatic Injury in Patients with Colorectal Liver Metastasis by Siripailin Siriwasunthra, Krittiya Korphaisarn, Yongyut Sirivatanauksorn, Somchai Limsrichamrern, Prawej Mahawithitwong, Prawat Kositamongkol, Chutwichai Tovikkai, Supreecha Asavakarn, Fern Chanduayvit, Ananya Pongpaibul
Published 2018-10-01
Article -
8
Obesity Significantly Affects the Incidence of Hepatic Injury in Patients with Colorectal Liver Metastasis by Siripailin Siriwasunthra, Krittiya Korphaisarn, Yongyut Sirivatanauksorn, Somchai Limsrichamrern, Prawej Mahawithitwong, Prawat Kositamongkol, Chutwichai Tovikkai, Supreecha Asavakarn, Fern Chanduayvit, Ananya Pongpaibul
Published 2018-10-01
Article -
9
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC) by Piyada Sitthideatphaiboon, Nicha Somlaw, Nicha Zungsontiporn, Pongsakorn Ouwongprayoon, Narittee Sukswai, Krittiya Korphaisarn, Naravat Poungvarin, Chatchawit Aporntewan, Nattiya Hirankarn, Chanida Vinayanuwattikun, Vinayanuwattikun Chanida
Published 2024-11-01
Article -
10
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer by Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Krittiya Korphaisarn, Nophol Leelayuwatanakul, Nopporn Pornpatrananrak, Naravat Poungvarin, Poonchavist Chantranuwat, Shanop Shuangshoti, Chatchawit Aporntewan, Wariya Chintanapakdee, Virote Sriuranpong, Chanida Vinayanuwattikun
Published 2022-02-01
Article -
11
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study by Chanchai Charonpongsuntorn, Suebpong Tanasanvimon, Krittiya Korphaisarn, Songwit Payapwattanawong, Teerada Siripoon, Nussara Pakvisal, Jitlada Juengsamarn, Ekkamol Phaibulvatanapong, Jarin Chindaprasirt, Naiyarat Prasongsook, Kittipong Udomdamrongkul, Nuttapong Ngamphaiboon, Ekaphop Sirachainan
Published 2022-12-01
Article -
12
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma by Orawan Suppramote, Orawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, Ben Ponvilawan, Jiradej Makjaroen, Monthira Suntiparpluacha, Krittiya Korphaisarn, Komgrid Charngkaew, Rawisak Chanwat, Trairak Pisitkun, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Published 2022-05-01
Article -
13
Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma by Sunisa Prasopporn, Sunisa Prasopporn, Orawan Suppramote, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Somponnat Sampattavanich, Siwanon Jirawatnotai, Siwanon Jirawatnotai
Published 2022-11-01
Article -
14
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma by Sunisa Prasopporn, Sunisa Prasopporn, Orawan Suppramote, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Somponnat Sampattavanich, Siwanon Jirawatnotai, Siwanon Jirawatnotai
Published 2023-01-01
Article -
15
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer by Shailesh Mahesh Advani, Pragati Shailesh Advani, Derek W. Brown, Stacia M. DeSantis, Krittiya Korphaisarn, Helena M. VonVille, Jan Bressler, David S. Lopez, Jennifer S. Davis, Carrie R. Daniel, Amir Mehrvarz Sarshekeh, Dejana Braithwaite, Michael D. Swartz, Scott Kopetz
Published 2019-10-01
Article -
16
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries by Choong-kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, David Wai Meng Tai, Hyeyeong Kim, Krittiya Korphaisarn, Suebpong Tanasanvimon, San-Chi Chen, Ju Won Kim, Ilhwan Kim, Moonho Kim, Joan Choo, Sang-Bo Oh, Ching-Tso Chen, Woo Kyun Bae, Hongsik Kim, Seok Jae Huh, Chia-Jui Yen, Sejung Park, Dong Ki Lee, Landon Long Chan, Beodeul Kang, Minsu Kang, Raghav Sundar, Hye Jin Choi, Stephen Lam Chan, Hong Jae Chon, Myung-Ah Lee
Published 2024-08-01
Article